Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry (Q88106792)
Jump to navigation
Jump to search
scientific article published on 01 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry |
scientific article published on 01 September 2014 |
Statements
Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry (English)
Heinrike Schmeling
Kirsten Minden
Ivan Foeldvari
Gerd Ganser
Tony Hospach